McCoy JG, Strecker RE.
2011.
The cognitive cost of sleep lost.. Neurobiol Learn Mem. 96(4):564-82.
Wallisch WJohn, Kidd B, Shen L, Hammer R, Siscel J.
2023.
Coagulopathy and Emergent Reversal of Anticoagulation.. Anesthesiol Clin. 41(1):249-261.
Emhardt EA, Hirst PC, Safavynia SA.
2021.
Clinicians' Attention in Today's Overstimulated World.. Crit Care Med. 49(5):e549-e551.
Savarese JJ.
1986.
Clinical relaxation: current controversy.. Can Anaesth Soc J. 33(3 Pt 2):S1-4.
Ali HH, Savarese JJ, Embree PB, Basta SJ, Stout RG, Bottros LH, Weakly JN.
1988.
Clinical pharmacology of mivacurium chloride (BW B1090U) infusion: comparison with vecuronium and atracurium.. Br J Anaesth. 61(5):541-6.
Belmont MR, Lien CA, Tjan J, Bradley E, Stein B, Patel SS, Savarese JJ.
2004.
Clinical pharmacology of GW280430A in humans.. Anesthesiology. 100(4):768-73.
Basta SJ, Savarese JJ, Ali HH, Embree PB, Schwartz AF, Rudd GD, Wastila WB.
1988.
Clinical pharmacology of doxacurium chloride. A new long-acting nondepolarizing muscle relaxant.. Anesthesiology. 69(4):478-86.
Savarese JJ, Ali HH, Basta SJ, Sunder N, Moss J, Gionfriddo MA, Lineberry CG, Wastila WB, el-Sayad HA, Montague D et al..
1983.
The clinical pharmacology of BW A444U. A nondepolarizing ester relaxant of intermediate duration.. Anesthesiology. 58(4):333-41.
Scott RP, Savarese JJ, Basta SJ, Embree P, Ali HH, Sunder N, Hoaglin DC.
1986.
Clinical pharmacology of atracurium given in high dose.. Br J Anaesth. 58(8):834-8.
Basta SJ, Ali HH, Savarese JJ, Sunder N, Gionfriddo M, Cloutier G, Lineberry C, Cato AE.
1982.
Clinical pharmacology of atracurium besylate (BW 33A): a new non-depolarizing muscle relaxant.. Anesth Analg. 61(9):723-9.
Belmont MR, Lien CA, Quessy S, Abou-Donia MM, Abalos A, Eppich L, Savarese JJ.
1995.
The clinical neuromuscular pharmacology of 51W89 in patients receiving nitrous oxide/opioid/barbiturate anesthesia.. Anesthesiology. 82(5):1139-45.
McKenna JTimothy, Christie MA, Jeffrey BA, McCoy JG, Lee E, Connolly NP, Ward CP, Strecker RE.
2012.
Chronic ramelteon treatment in a mouse model of Alzheimer's disease.. Arch Ital Biol. 150(1):5-14.
Ivascu NS, Sarnaik S, McCrae J, Whitten-Shurney W, Thomas R, Bond S.
2001.
Characterization of pica prevalence among patients with sickle cell disease.. Arch Pediatr Adolesc Med. 155(11):1243-7.